NZ505608A - Fat blend - Google Patents
Fat blendInfo
- Publication number
- NZ505608A NZ505608A NZ505608A NZ50560898A NZ505608A NZ 505608 A NZ505608 A NZ 505608A NZ 505608 A NZ505608 A NZ 505608A NZ 50560898 A NZ50560898 A NZ 50560898A NZ 505608 A NZ505608 A NZ 505608A
- Authority
- NZ
- New Zealand
- Prior art keywords
- fatty acids
- fat blend
- acid
- gamma
- eicosapentaenoic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 235000019197 fats Nutrition 0.000 abstract 4
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 3
- 229930195729 fatty acid Natural products 0.000 abstract 3
- 239000000194 fatty acid Substances 0.000 abstract 3
- 150000004665 fatty acids Chemical class 0.000 abstract 3
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 abstract 2
- 235000005911 diet Nutrition 0.000 abstract 2
- 230000000378 dietary effect Effects 0.000 abstract 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 abstract 2
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 abstract 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 1
- 208000017667 Chronic Disease Diseases 0.000 abstract 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 abstract 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 1
- 229960002733 gamolenic acid Drugs 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000036737 immune function Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 229940067606 lecithin Drugs 0.000 abstract 1
- 235000010445 lecithin Nutrition 0.000 abstract 1
- 239000000787 lecithin Substances 0.000 abstract 1
- 230000037356 lipid metabolism Effects 0.000 abstract 1
- 230000002366 lipolytic effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pediatric Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Edible Oils And Fats (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Lubricants (AREA)
- Fats And Perfumes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19757414A DE19757414A1 (de) | 1997-12-23 | 1997-12-23 | Fettmischung |
| PCT/EP1998/008409 WO1999033355A2 (de) | 1997-12-23 | 1998-12-22 | Fettmischung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ505608A true NZ505608A (en) | 2002-12-20 |
Family
ID=7853100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ505608A NZ505608A (en) | 1997-12-23 | 1998-12-22 | Fat blend |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7045143B1 (xx) |
| EP (1) | EP1041896B1 (xx) |
| JP (1) | JP2001526908A (xx) |
| CN (1) | CN1091363C (xx) |
| AT (1) | ATE213391T1 (xx) |
| AU (1) | AU758079B2 (xx) |
| BR (1) | BR9814467A (xx) |
| CA (1) | CA2316298C (xx) |
| DE (2) | DE19757414A1 (xx) |
| DK (1) | DK1041896T3 (xx) |
| ES (1) | ES2173673T3 (xx) |
| NO (1) | NO316302B1 (xx) |
| NZ (1) | NZ505608A (xx) |
| WO (1) | WO1999033355A2 (xx) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19757414A1 (de) | 1997-12-23 | 1999-07-01 | Nutricia Nv | Fettmischung |
| DE19914104A1 (de) * | 1999-03-23 | 2000-09-28 | Siegfried Seifert | Verfahren zur Verbesserung der körperlichen Erscheinung eines Menschen unter Verabreichung einer Fett-Eiweiß-Diät |
| US6340705B1 (en) * | 1999-09-10 | 2002-01-22 | Monsanto Technology, Llc | Use of α-linolenic acid metabolites for treatment or prevention of cancer |
| WO2001024812A1 (en) * | 1999-10-06 | 2001-04-12 | N.V. Nutricia | USE OF TRANSFORMING GROWTH FACTOR β AND GROWTH FACTORS IN THE TREATMENT AND PREVENTION OF DISEASES OF THE INTESTINAL MUCOSA |
| GB0016045D0 (en) | 2000-06-29 | 2000-08-23 | Laxdale Limited | Therapeutic combinations of fatty acids |
| US6667064B2 (en) * | 2000-08-30 | 2003-12-23 | Pilot Therapeutics, Inc. | Composition and method for treatment of hypertriglyceridemia |
| WO2002092073A1 (en) * | 2001-05-14 | 2002-11-21 | Martek Biosciences Corporation | Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes |
| WO2002092779A2 (en) * | 2001-05-17 | 2002-11-21 | Pilot Therapeutics, Inc. | Method for enriching tissues in long chain polyunsaturated fatty acids |
| JP2005519939A (ja) * | 2002-03-08 | 2005-07-07 | モンサント テクノロジー エルエルシー | 炎症性疾患の治療および予防 |
| DE10254584A1 (de) * | 2002-11-22 | 2004-06-09 | HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie | Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker |
| DE10361667A1 (de) * | 2003-12-30 | 2005-07-28 | Omega For Life Gmbh | Neuartige Fettpulver |
| EP1723951A1 (en) * | 2005-04-21 | 2006-11-22 | N.V. Nutricia | Nutritional supplement with oligosaccharides for a category of HIV patients |
| JP5069121B2 (ja) * | 2004-11-12 | 2012-11-07 | エヌ．ブイ．・ヌートリシア | 炎症反応を急激に軽減させる食品組成物 |
| US20090318394A1 (en) * | 2004-11-19 | 2009-12-24 | Julie Nauroth | Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same |
| KR20070090928A (ko) | 2004-11-19 | 2007-09-06 | 마텍 바이오싸이언스스 코포레이션 | 장쇄 다가불포화 지방산으로부터의 옥시리핀, 및 이의 제조방법 및 사용 방법 |
| US7893106B2 (en) * | 2004-11-19 | 2011-02-22 | Martek Biosciences, Corporation | Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same |
| US20090252853A1 (en) * | 2005-11-30 | 2009-10-08 | Angel Gil Hernandez | Lipid Mixture and Use Thereof in the Preparation of a Product That Is Intended for Enteral or Oral Administration |
| PL1800675T4 (pl) | 2005-12-23 | 2012-02-29 | Nutricia Nv | Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia |
| WO2007090162A2 (en) * | 2006-01-31 | 2007-08-09 | Martek Biosciences Corporation | OXYLIPINS FROM STEARIDONIC ACID AND γ-LINOLENIC ACID AND METHODS OF MAKING AND USING THE SAME |
| EP2007215A4 (en) * | 2006-04-11 | 2011-04-13 | Martek Biosciences Corp | FOODSTUFFS WITH LONG-CHAIN MULTIPLE-UNSATURATED FATTY ACIDS AND METHOD FOR THE PRODUCTION THEREOF |
| GB0612671D0 (en) * | 2006-06-27 | 2006-08-09 | Shs Int Ltd | Nutritional formulation |
| US20080089981A1 (en) * | 2006-10-17 | 2008-04-17 | N.V. Nutricia | Ketogenic diet |
| CA2567879C (en) * | 2006-11-14 | 2013-03-26 | Thomas Greither | Nutritional food oil compositions and methods of making same |
| GB2444896B (en) * | 2006-12-18 | 2010-05-19 | Nutraceuticals Ltd | Compositions comprising polyunsaturated fatty acids |
| US20110190389A1 (en) * | 2007-02-20 | 2011-08-04 | Linda Arterburn | Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same |
| US8652508B2 (en) * | 2007-05-25 | 2014-02-18 | Children's Medical Center Corporation | Dietary formulations and methods for treatment of inflammation and other disorders |
| AU2008307494B2 (en) * | 2007-10-04 | 2013-09-05 | Société des Produits Nestlé S.A. | Compositions and methods for enhancing cognitive function |
| WO2009073397A1 (en) * | 2007-11-29 | 2009-06-11 | Monsanto Technology Llc | Meat products with increased levels of beneficial fatty acids |
| US20110027841A1 (en) * | 2007-12-21 | 2011-02-03 | Martek Biosciences Corporation | Method for preparation of oxylipins |
| US20100266746A1 (en) * | 2009-04-16 | 2010-10-21 | Monsanto Technology Llc | Spread formulations including stearidonic acid |
| IN2012DN00563A (xx) * | 2009-07-15 | 2015-06-12 | Solae Llc | |
| CA2773793A1 (en) * | 2009-09-30 | 2011-04-07 | Solae, Llc | Omega-3 fatty acid enriched shortenings and nut butters |
| WO2011071365A1 (en) * | 2009-12-07 | 2011-06-16 | N.V. Nutricia | Balanced fat composition and use thereof in a liquid nutritional composition suitable for enteral feeding |
| US20120277316A1 (en) * | 2010-01-19 | 2012-11-01 | University of Tennesse Research Foundation a university | Methods and compositions for treating and preventing parenteral nutrition associated liver disease |
| US8372465B2 (en) * | 2010-02-17 | 2013-02-12 | Bunge Oils, Inc. | Oil compositions of stearidonic acid |
| EP2658403B1 (en) * | 2010-12-29 | 2018-05-02 | Abbott Laboratories | Nutritional product for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child |
| US20120252888A1 (en) * | 2011-03-29 | 2012-10-04 | Palupa Medical Ltd. | Compositions and Methods for Treating Neurologic Disorders |
| WO2012138212A1 (en) | 2011-04-06 | 2012-10-11 | N.V. Nutricia | Food composition for intra-operative tube feeding |
| US8728546B1 (en) | 2013-03-15 | 2014-05-20 | Swing Aerobics Licensing, Inc. | Medicament for treatment of cancer, cardiovascular diseases and inflammation |
| US20150157048A1 (en) * | 2013-12-11 | 2015-06-11 | Mead Johnson Nutrition Company | Nutritional compositions containing stearidonic acid and uses thereof |
| US11419350B2 (en) | 2016-07-01 | 2022-08-23 | Corbion Biotech, Inc. | Feed ingredients comprising lysed microbial cells |
| CN109527123A (zh) * | 2018-12-14 | 2019-03-29 | 大连大学 | 一种对慢性肠炎具有改善作用的调和油 |
| CN112891304B (zh) * | 2020-10-14 | 2022-06-10 | 麦孚营养科技有限公司 | 一种高能量密度的脂肪乳剂及其制备方法和其应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3924607A1 (de) * | 1989-07-21 | 1991-01-24 | Singer Peter Dr Sc Med | Diaetetisches nahrungs- oder genussmittel |
| DK0457950T3 (da) * | 1990-05-23 | 1994-03-07 | Nestle Sa | Anvendelse af stearidonsyre til behandling af inflammatorisk betingede sygdomme |
| US5922345A (en) * | 1990-12-07 | 1999-07-13 | Scotia Holdings Plc | Nutrition |
| GB9026648D0 (en) * | 1990-12-07 | 1991-01-23 | Efamol Holdings | Nutrition |
| US5223285A (en) * | 1992-03-31 | 1993-06-29 | Abbott Laboratories | Nutritional product for pulmonary patients |
| AU683027B2 (en) * | 1993-01-27 | 1997-10-30 | Scotia Holdings Plc | Triglycerides |
| CA2119000A1 (en) * | 1993-03-19 | 1994-09-20 | David Frederick Horrobin | Formulation for use in smokers |
| US5714472A (en) | 1993-12-23 | 1998-02-03 | Nestec Ltd. | Enternal formulation designed for optimized nutrient absorption and wound healing |
| GB9506837D0 (en) * | 1995-04-03 | 1995-05-24 | Scotia Holdings Plc | Triglycerides |
| DE19528461A1 (de) * | 1995-08-03 | 1997-02-06 | Braun Melsungen Ag | Präparat zur Ernährung |
| AU2290297A (en) * | 1996-03-26 | 1997-10-17 | Gist-Brocades B.V. | Late addition of pufa in infant formula preparation process |
| US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
| DE69622722T2 (de) * | 1996-11-20 | 2003-02-27 | N.V. Nutricia, Zoetermeer | Fette enthaltende Ernährungszusammensetzung zur Behandlung des Stoffwechselsyndroms |
| DE19757414A1 (de) | 1997-12-23 | 1999-07-01 | Nutricia Nv | Fettmischung |
-
1997
- 1997-12-23 DE DE19757414A patent/DE19757414A1/de not_active Withdrawn
-
1998
- 1998-12-22 BR BR9814467-7A patent/BR9814467A/pt not_active Application Discontinuation
- 1998-12-22 AT AT98966662T patent/ATE213391T1/de active
- 1998-12-22 DK DK98966662T patent/DK1041896T3/da active
- 1998-12-22 CA CA002316298A patent/CA2316298C/en not_active Expired - Fee Related
- 1998-12-22 US US09/581,520 patent/US7045143B1/en not_active Expired - Fee Related
- 1998-12-22 ES ES98966662T patent/ES2173673T3/es not_active Expired - Lifetime
- 1998-12-22 AU AU24162/99A patent/AU758079B2/en not_active Ceased
- 1998-12-22 JP JP2000526127A patent/JP2001526908A/ja active Pending
- 1998-12-22 EP EP98966662A patent/EP1041896B1/de not_active Expired - Lifetime
- 1998-12-22 WO PCT/EP1998/008409 patent/WO1999033355A2/de not_active Ceased
- 1998-12-22 NZ NZ505608A patent/NZ505608A/xx not_active IP Right Cessation
- 1998-12-22 DE DE59803153T patent/DE59803153D1/de not_active Expired - Lifetime
- 1998-12-22 CN CN98812474A patent/CN1091363C/zh not_active Expired - Fee Related
-
2000
- 2000-06-22 NO NO20003265A patent/NO316302B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1033541A1 (en) | 2001-09-07 |
| ES2173673T3 (es) | 2002-10-16 |
| NO20003265D0 (no) | 2000-06-22 |
| CN1091363C (zh) | 2002-09-25 |
| EP1041896A2 (de) | 2000-10-11 |
| ATE213391T1 (de) | 2002-03-15 |
| US7045143B1 (en) | 2006-05-16 |
| BR9814467A (pt) | 2000-10-10 |
| JP2001526908A (ja) | 2001-12-25 |
| NO316302B1 (no) | 2004-01-12 |
| AU2416299A (en) | 1999-07-19 |
| NO20003265L (no) | 2000-06-22 |
| WO1999033355A3 (de) | 1999-09-16 |
| DK1041896T3 (da) | 2002-06-17 |
| DE59803153D1 (de) | 2002-03-28 |
| CN1282223A (zh) | 2001-01-31 |
| CA2316298A1 (en) | 1999-07-08 |
| AU758079B2 (en) | 2003-03-13 |
| DE19757414A1 (de) | 1999-07-01 |
| WO1999033355A2 (de) | 1999-07-08 |
| CA2316298C (en) | 2008-11-18 |
| EP1041896B1 (de) | 2002-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ505608A (en) | Fat blend | |
| Nordström et al. | Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed | |
| EP1296670B1 (en) | Therapeutic combinations of fatty acids | |
| DK1121115T3 (da) | PUFA-tilskud | |
| US5059622A (en) | Method for reducing blood pressure levels in hypertensive persons | |
| AU677275B2 (en) | Formulation for use in smokers | |
| JP2796838B2 (ja) | 精神分裂症および／または関連した晩発性運動障害の治療のための薬剤を製造する方法 | |
| EP0815735A3 (fr) | Produit laitier diététiquement équilibré | |
| MXPA03001796A (es) | Composicion y metodo para el tratamiento de hipertrigliceridemia. | |
| SG64864A1 (en) | Phospholipids | |
| JPH08500332A (ja) | 炎症性疾患の治療のための非経口的に投与される医薬を調製するためのエマルジョンの使用 | |
| IE67622B1 (en) | Efa compositions and therapy | |
| DE3570362D1 (en) | Pharmaceutical or dietetic composition having a high antithrombotic and antiarteriosclerotic activity | |
| JPH04290821A (ja) | 液体栄養副作用の予防方法またはそれに用いる薬剤の製造方法 | |
| Cleland et al. | Omega-6/Omega-3 Fatty Acids | |
| Peck | Essential fatty acid deficiency in renal failure: can supplements really help? | |
| AU1489688A (en) | Omega-3 fatty acids in traumatic injury treatment | |
| JPH04152861A (ja) | 栄養補給用栄養組成物 | |
| JP2537645B2 (ja) | 薬剤的活性を有する栄養組成物 | |
| Tamargo et al. | Pharmacokinetics and safety profile of omega-3 polyunsaturated fatty acids | |
| CA1334002C (en) | Essential fatty acid compositions and methods for the modulation of prostaglandin levels in mammals | |
| Minnis et al. | Oily fish and fish oil supplements in the prevention of coronary heart disease | |
| Maki et al. | Bioavailability of eicosapentaenoic and docosahexaenoic n‐3 polyunsaturated fatty acids in salmon patties compared with capsules | |
| Oostenbrug et al. | A moderate in vivo vitamin E supplement counteracts the fish-oil-induced increase in in vitro oxidation of human low-density lipoproteins | |
| JP2001064171A (ja) | 脱共役蛋白質発現誘導剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| EXPY | Patent expired |